Advertisement

NLS Acquisition

Acquisition - February 12, 2024

RaySearch acquires product from Pharmacolog

RaySearch have announces the acquisition of DrugLog from Pharmacolog for the purchase price of SEK 7 million. DrugLog is a solution for verifying the identity and concentration of compounded injectable medications, used for cancer treatment with cytostatic drugs (chemotherapy). Through this agreement, RaySearch acquires full ownership of all rights to the product for its application […]

Acquisition - February 6, 2024

Novo Holdings to acquire Catalent

Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at USD 16.5 billion on an enterprise value basis. Novo Holdings, a holding and investment company that is responsible for managing the assets and wealth of the Novo Nordisk Foundation, will acquire all outstanding shares of CDMO Catalent for USD 63.50 per share […]

Acquisition - January 16, 2024

Key2Compliance acquired by GBA Group

With the acquisition GBA Group is expanding its range of consulting and training services for the medical device, In Vitro Diagnostics (IVD), and pharmaceutical industry. “As we have set ourselves the goal of being a broad-based service provider for medical devices, Key2Compliance, with its consulting and training services and expertise, is a perfect fit for […]

Acquisition - January 7, 2024

AstraZeneca to acquire Gracell

AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies Inc, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases. The proposed acquisition will enrich AstraZeneca’s growing pipeline of cell therapies with GC012F, a novel, clinical-stage FasTCAR-enabled BCMA and CD19 dual-targeting autologous chimeric antigen receptor T-cell (CAR-T) […]

Acquisition - December 12, 2023

AstraZeneca to acquire Icosavax

AstraZeneca has entered into a definitive agreement to acquire Icosavax, a US-based clinical-stage biopharma company focused on developing vaccines using a protein virus-like particle (VLP) platform. The proposed acquisition will build on AstraZeneca’s expertise in respiratory syncytial virus (RSV), strengthening AstraZeneca’s Vaccines & Immune Therapies late-stage pipeline with Icosavax’s lead investigational vaccine candidate, IVX-A12, the […]

Acquisition - December 11, 2023

Mentice enters agreement to acquire all substantial assets from Biomodex

The global Biomodex business reached a total turnover of EUR 2.2 million in 2022. Biomodex specializes in biorealistic 3D printing and flow systems for interventional procedures, with a platform geared towards clinical use and patient-specific simulation. As part of the acquisition, Mentice will also retain key employees of Biomodex. “Biomodex is truly a quality product […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.